Nicole R. Hadas has sold AKBA and made no open-market buys since Oct 2017
SVP and General Counsel at Akebia Therapeutics, Inc.
SEC CIK 0001602396 · Filings on SEC.gov ↗
$0Bought
$388KSold
NoneLast buy
Every filing
5 filings since Oct 2017, newest first
AKBASell
Akebia Therapeutics, Inc.
SVP and General Counsel
$77K−11.0%May 25
AKBASell
Akebia Therapeutics, Inc.
SVP and General Counsel
$46K−6.0%Mar 2
AKBASell
Akebia Therapeutics, Inc.
SVP and General Counsel
$49K−5.0%Mar 2
AKBASell
Akebia Therapeutics, Inc.
SVP and General Counsel
$61K−3.0%Mar 2
AKBASell
Akebia Therapeutics, Inc.
SVP, GC, Sec.
$155K−7.0%Oct 4
Filings come from SEC EDGAR. Not investment advice.